Logo Logo
Switch Language to German
Schuller, Marion; Höfner, Georg; Wanner, Klaus T. (2017): Simultaneous Multiple MS Binding Assays Addressing D-1 and D-2 Dopamine Receptors. In: ChemMedChem, Vol. 12, No. 19: pp. 1585-1594
Full text not available from 'Open Access LMU'.


MS Binding Assays are a label-free alternative to radioligand binding assays. They provide basically the same capabilities as the latter, but use a non-labeled reporter ligand instead of a radioligand. In contrast to radioligand binding assays, MS Binding Assays offerowing to the selectivity of mass spectrometric detectionthe opportunity to monitor the binding of different reporter ligands at different targets simultaneously. The present study shows a proof of concept for this strategy as exemplified for MS Binding Assays selectively addressing D-1 and D-2 dopamine receptors in a single binding experiment. A highly sensitive, rapid and robust LC-ESI-MS/MS quantification method capable of quantifying both SCH23390 and raclopride, selectively addressing D-1 and D-2 receptors, respectively, was established and validated for this purpose. Based thereon, simultaneous saturation and competition experiments with SCH23390 and raclopride in the presence of both D-1 and D-2 receptors were performed and analyzed by LC-MS/MS within a single chromatographic cycle. The present study thus demonstrates the feasibility of this strategy and the high versatility of MS Binding Assays that appears to surpass that common for conventional radioligand binding assays.